![PAT-1251 de dipotassium Further evaluation of [11C]MP-10 as](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M19543_1635186497.gif?v=1635186498)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis
BAY-985 is a potent and highly selective TBK1/IKKε inhibitor
210303-49-4 ((Z)-SU5402)
Imatinib inhibits the SLF-dependent activation of wild-type c-kit kinase activity with a IC50 for these effects of approximately 0
is a HTT-LC3 linker compound
PAT-1251 de dipotassium Further evaluation of [11C]MP-10 asPAT 1251 is a potent, selective and oral lysyl oxidase like 2 (LOXL2) inhibitor, with IC50s of 0. 71 and 1. 17 M for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0. 10, 0. 12, and 0. 16 M, respectively); PAT 1251 is used in the research of fibrotic diseases. Product information CAS Number: 2007885 39 2 Molecular Weight: 399. 34 Formula: C18H17F4N3O3 Chemical Name: (3R,4R) 1 (3 {[4 (aminomethyl) 6
US$ 249.00
US$ 116.75
US$ 139.97
US$ 197.95
US$ 188.95
US$ 11.99
US$ 265.48